Chronic liver allograft dysfunction

Transplant Proc. 2009 Mar;41(2):773-6. doi: 10.1016/j.transproceed.2009.01.038.

Abstract

Approximately 90% of liver transplant patients are alive after 1 year and 75% after 5 years with the majority leading full and near-normal lives. However, although early mortality rates after transplantation have fallen dramatically over the last 2 decades, the rates of late graft loss and patient death have remained constant. Thus, understanding of the causes of graft and patient failure is essential to improve long-term outcomes. In the early days after liver transplantation, ischemia and reperfusion injuries predominate, with acute cellular rejection relatively common in first 3 months. Thereafter, the causes of graft dysfunction are variable with disease recurrence as a major cause of graft loss. In this review, we discuss causes of graft dysfunction after 6 months.

Publication types

  • Review

MeSH terms

  • Cause of Death
  • Graft Rejection / immunology
  • Graft Rejection / mortality
  • Graft Rejection / pathology
  • Hepatitis / mortality
  • Hepatitis B / mortality
  • Hepatitis B / surgery
  • Hepatitis C / mortality
  • Hepatitis C / surgery
  • Hepatitis, Autoimmune / mortality
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Immunosuppressive Agents / toxicity
  • Liver Cirrhosis / mortality
  • Liver Transplantation / adverse effects*
  • Liver Transplantation / immunology
  • Liver Transplantation / mortality
  • Recurrence
  • Reperfusion Injury / mortality
  • Reperfusion Injury / pathology
  • Survival Analysis
  • Survivors
  • Transplantation, Homologous / adverse effects*
  • Transplantation, Homologous / immunology
  • Transplantation, Homologous / mortality

Substances

  • Immunosuppressive Agents